We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kooth Plc | LSE:KOO | London | Ordinary Share | GB00BMCZLK30 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
7.00 | 2.33% | 307.00 | 304.00 | 310.00 | 308.00 | 298.00 | 298.00 | 153,786 | 15:53:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Spec Outpatient Facility,nec | 20.12M | -716k | -0.0217 | -141.47 | 101.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/10/2022 08:01 | And it keeps falling | hybrasil | |
18/9/2022 08:00 | This is still valued at £38m. Strip out the £8m of cash - that’s £30m FFS. in its last set of results it only turned over £16m - if my memory is right. It is a screaming sell. Worth about 20p. Maximum | hybrasil | |
26/7/2022 15:56 | Hard to value hybrasil which is why i am on the sidelines. Just watching with interest as previously invested at IPO. Agree hard to raise cash my point was they don’t need to and it was a concern of mine with the US expansion but its all looking self funding for now. Last year 2xARR would be cheap, in 2022-23 i have no idea what is cheap anymore! | rimau1 | |
26/7/2022 13:34 | Rimau It’s nigh on impossible to raise equity in the current market. Agree increase in cash a good sign but £40m mcap?? | hybrasil | |
26/7/2022 07:43 | Given the price action over the past 6 months i was expecting a nasty surprise in the TU but there were only 2 amber flags for me (1) a slow down in new business spending decisions with the reorganisation of the NHS regional structures (2) no mention of ARR which is a key metric for Kooth. I was hoping this would continue to track up towards £20m. The good news; Net cash was up (i didn’t expect that) and no sign of an equity raise. Of course they will be capex’ing everything so its not capital light but the balance sheet should be sufficient for the existing growth plans. | rimau1 | |
20/7/2022 15:04 | Worth at most half the current share price. I’d say it’s pass the parcel time | hybrasil | |
12/7/2022 10:45 | This in my view is massively overvalued. I think its a screaming short. Its a tech share set up by software people. Compare its number to for instance totally. The turnover to market cap ratio is daft in this market. | hybrasil | |
05/4/2022 15:17 | Hi rimau1 i am considering buying in now. As you say, it is hard to value. I will be staying in for the long haul though, as i believe that the need for mental health support will only increase. We are living in a time of constant emergencies and anxiety, depression and confusion will only increase. The trend of everything being online will most likely continue also. This seems to marry the two together. I have no idea if this particular company will succeed, but it feels good to invest in this sector. The only other company that i know of in the mental health sector, and it is quite different is COG and the share price has shot back up towards all time highs. I prefer buying low. Kooth do appear to have conviction with their growth. I think this is a good long-term buy and hold. There appears very little info on it. I saw Midas tipped it back in January when the share price was £3.19 | markr5 | |
28/3/2022 14:58 | I’ve taken some more at £2.38, results this week could halt the slide. Hard to value but i just have a very deep conviction in this structural growth play, what other stock is out there to invest in if you want to play the Mental Health sector? Hoping for an update on US expansion which could be a catalyst. I will keep talking to myself…… | rimau1 | |
16/3/2022 09:13 | Great unexpected update. Forward looking ARR should be approaching £18m now so this is looking cheap. To the extent that they can KOO have a monopoly in the UK as they cover c.90% of the young adult market so extending contracts to Adults with the existing customers (NHS trusts) should be almost guaranteed. Lucrative Corporate market excites me. Expansion into the US makes me a little nervous as that has gone quiet since the US hire. Expect an update on US progress before results in Q2. | rimau1 | |
19/1/2022 11:07 | To be fair I only sourced a TU today from the midas report. Last year was the 21 Jan i think so it could land anytime this month. | rimau1 | |
19/1/2022 08:03 | no trading update ? | jeanesy | |
18/1/2022 16:52 | Trading update Wednesday. Looking for £17m revenues and breaking even. More importantly i want to see traction in the lucrative corporate space and an update on US expansion plans. | rimau1 | |
16/1/2022 11:24 | Nice write up in Midas today. | rimau1 | |
21/4/2021 08:31 | Excellent news on the adult expansion. I enjoy a BB talking to myself it means this continues to be under the radar! | rimau1 | |
06/4/2021 14:25 | All looking good here, Kooth keeps flying under the radar. I wonder how our US and adult expansion is going. | rimau1 | |
25/1/2021 10:26 | Investor's Champion comments that the shares are up 35% since listing, pushing the market capitalisation to £89m. It certainly looks a fascinating business. Check their latest Blog: Online platforms have proven themselves over a testing period and should continue to do well as the move online accelerates. #koo #ltg #sge #zyt | energeticbacker | |
25/1/2021 08:12 | Good article in Sunday Times yesterday. Just topped up | blondviking | |
24/1/2021 10:59 | Not yet - just hit an one of my "interest" screens | pugugly | |
24/1/2021 10:55 | I prefer under the radar Pug! Do you hold? | rimau1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions